Skip to content

Tectonic Therapeutics TECX Retained Earnings

Retained Earnings at other companies

ALN
Alnylam PharmaceuticalsALNY
-$6.5B+11.6%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$175.89M-25.8%
Regenxbio logo
RegenxbioRGNX
-$1.22B-31.3%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
-$77.67M-9.8%
Opko Health logo
Opko HealthOPK
-$2.35B-10.0%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$6.23B-5.1%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's retained earnings?
Tectonic Therapeutics (TECX) reported retained earnings of -$247.98M in Q1 2026.
How has Tectonic Therapeutics's retained earnings changed year-over-year?
Tectonic Therapeutics's retained earnings decreased by 50.8% year-over-year, from -$164.49M to -$247.98M.
What is the long-term trend for Tectonic Therapeutics's retained earnings?
Over 5 years (2020 to 2025), Tectonic Therapeutics's retained earnings has grown at a -3.4% compound annual growth rate (CAGR), from -$264.42M to -$222.74M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.